Navigation Links
Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer

that RTA 402 has potent single-agent anti-cancer activity in patients with several different types of tumors, is exceptionally well tolerated with only mild, transient side effects, inhibits the activity of NF-kB and STAT3 (the drug's targets) in human tumors, and is able to suppress levels of tumor promoting cytokines and growth factors (for example, TNF and VEGF) at very low doses. Reata is also advancing a second Synthetic Triterpenoid capable of crossing the blood-brain barrier for neurological indications including multiple sclerosis, Alzheimer's disease, and Parkinson's disease. This agent is in advanced preclinical development.

In the "Nature Reviews Cancer" article, the researchers provide a comprehensive overview of the discovery and activity of these agents. The authors note that Reata's Synthetic Triterpenoids have profound effects on inflammation and the redox state of cells and tissues, as well as being potent anti-proliferative and pro-apoptotic agents. Because of their unique pharmacology, these agents are being studied at leading research institutions and are the subject of more than 50 publications in peer reviewed journals. The article summarizes the current state of this literature. Some highlights of this comprehensive body of research reviewed in the article include the following:

-- How the drugs were optimized to inhibit the de novo synthesis of iNOS and COX2 in normal mouse macrophages. iNOS and COX2 have essential roles in the initiation of inflammation.

-- An explanation of the drugs' molecular targets and mechanism of action. The synthetic triterpenoids are potent inhibitors of transcription factors such as NF-kB and the STATs that are normally activated by reactive oxygen and nitrogen species. Inhibition is achieved by activation of the antioxidant transcription factor Nrf2, which activates the phase 2 genes and reduces cellular levels of reactive oxygen and nitrogen species. In addition, the triterpenoids directly re
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
2. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
3. Targeting Specific Mutations Reveals Promising New Approach to Treating Genetic Disorders; Preclinical Data Published in Nature
4. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
5. Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology
6. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
7. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
8. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
9. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
10. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reata Synthetic Triterpenoids Profiled Nature Reviews Cancer
(Date:5/22/2015)... , May 22, 2015 Today, ... central nervous system stimulant indicated for the treatment ... patients beginning Summer 2015. The ... received approval from the U.S. Food and Drug ... an extended-release formulation of methylphenidate capsule with an ...
(Date:5/22/2015)... LONDON , May 22, 2015 ... early phase clinical research unit with a worldwide ... respected for its frequent publications in peer reviewed ... and European stakeholders and regulators in discussions about ... results.      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
(Date:5/22/2015)... 22, 2015  China Nepstar Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based ... the resignation of Mr. Fuxiang Zhang as ... immediately. Ms. Rebecca Yingnan Zhang has been ... of directors, effective immediately. Meanwhile, Ms. Zhang resigned from ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3
... plc (Nasdaq: JAZZ ) today announced several ... company,s leadership team. The appointments include: ... company and will serve as general counsel and an ... in March.  Ms. Hooper is currently a partner at ...
... Sinovac Biotech Ltd. (Nasdaq: SVA ), a leading ... a letter dated January 18, 2012 from The Nasdaq Stock ... from the Company,s Board of Directors effective January 4, 2012, ... Nasdaq,s requirement that its audit committee consists of at least ...
Cached Medicine Technology:Jazz Pharmaceuticals plc Announces New Executive Appointments 2Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement 2
(Date:5/25/2015)... MA (PRWEB) May 25, 2015 A recent ... 2015 states 1,000 persons have died as a direct result ... 2014. This marks a 33% rise in overdose deaths attributed ... Charlie Baker, “This issue doesn’t care about geography. This issue ... This issue doesn’t care about class.” As the state of ...
(Date:5/25/2015)... 25, 2015 Join Fiona's Soccer Camp at ... instructional clinic. Irish National Player, Fiona O'Sullivan will be ... a taste of her coaching style. Fiona has three camps ... in Novato are at Lynwood Elmentary School (June 15-19) and ... School - June 6th, 2015 - 1:00-3:00pm. Bring a Soccer ...
(Date:5/25/2015)... 2015 Decora Preset 60 Minute Countdown ... available on ‘The Hardware City.’ The product helps in automatically ... a time and the related electronic device is automatically turned ... of the company said, “We are glad that this amazing ... can buy Countdown Timer Switch in just a few clicks. ...
(Date:5/24/2015)... May 24, 2015 For people who ... Chinese Enterokinase Industry, 2009-2019 Market Research Report would be ... an exhaustive study on the present market scenario of ... into the growing Chinese market of this industry. The ... overall status of the manufacturers in this industry. The ...
(Date:5/24/2015)... New York, New York (PRWEB) May 24, 2015 ... of testosterone treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) has ... discuss the progress of the multidistrict litigation. According ... Court, Northern District of Illinois, the Conference will ... p.m. (In re: Testosterone Replacement Therapy Product Liability ...
Breaking Medicine News(10 mins):Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3
... , WEDNESDAY, May 18 (HealthDay News) -- Although ... offer no benefit to patients suffering from pulmonary arterial ... blood pressure in the arteries of the lungs, according ... by the U.S. National Institutes of Health, researchers divided ...
... By Jenifer Goodwin HealthDay Reporter , WEDNESDAY, ... younger are now being treated for autism in Massachusetts, a ... born between 2001 and 2005 was enrolled in early intervention ... according to the study. Over the five-year period, the ...
... absorbed from the sun, plays a role in protection against ... has shown that children who live in colder, wetter cities ... since there are fewer hours of sunlight in such places. ... it,s also dangerous to avoid it. There has to be ...
... associated with outsized, supercooled, superconducting magnets, is one of ... study everything from alcohols to proteins to such frontiers ... cousin, magnetic resonance imaging (MRI), is as loud as ... for a wide range of medical conditions. ...
... NYU Langone Medical Center, one of the nation,s premier academic ... Medicine, NYU Physician, is now available as a free iPad ... published three times a year, provides news and insights about ... Each issue features a trio of in-depth articles focused on ...
... ARBOR, Mich. About half of prostate cancers have a ... a new class of cancer-fighting drugs, a new study from ... drugs, called PARP inhibitors, are currently being tested in breast ... which are found in up to 10 percent of all ...
Cached Medicine News:Health News:Standard Heart Drugs Won't Ease Pulmonary Hypertension 2Health News:Massachusetts Study Shows Sharp Rise in Early Autism Diagnoses 2Health News:Massachusetts Study Shows Sharp Rise in Early Autism Diagnoses 3Health News:Sun protects against childhood asthma 2Health News:Nuclear magnetic resonance with no magnets 2Health News:Nuclear magnetic resonance with no magnets 3Health News:Nuclear magnetic resonance with no magnets 4Health News:Nuclear magnetic resonance with no magnets 5Health News:Nuclear magnetic resonance with no magnets 6Health News:Half of prostate cancers could potentially benefit from new type of cancer drugs, U-M study finds 2
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use....
Inquire...
Used to obtain tissue biopsy under direct vision. Cup Biopsy Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in peel-open packages. Intended for one-time use....
... Brasseler USA™ MicroLine™ Small Bone Power ... operation while performing under the most ... system developed for small bone osteotomies ... Sagittal Saw (Extended Length Available), Oscillating ...
Medicine Products: